BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 26769995)

  • 1. Schistosomiasis in school-age children in Burkina Faso after a decade of preventive chemotherapy.
    Ouedraogo H; Drabo F; Zongo D; Bagayan M; Bamba I; Pima T; Yago-Wienne F; Toubali E; Zhang Y
    Bull World Health Organ; 2016 Jan; 94(1):37-45. PubMed ID: 26769995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso.
    Touré S; Zhang Y; Bosqué-Oliva E; Ky C; Ouedraogo A; Koukounari A; Gabrielli AF; Bertrand S; Webster JP; Fenwick A
    Bull World Health Organ; 2008 Oct; 86(10):780-7, A. PubMed ID: 18949215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
    Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
    Coulibaly JT; N'gbesso YK; Knopp S; Keiser J; N'Goran EK; Utzinger J
    PLoS Negl Trop Dis; 2012; 6(12):e1917. PubMed ID: 23236526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of intestinal parasitic infections and associated risk factors among schoolchildren in the Plateau Central and Centre-Ouest regions of Burkina Faso.
    Erismann S; Diagbouga S; Odermatt P; Knoblauch AM; Gerold J; Shrestha A; Grissoum T; Kaboré A; Schindler C; Utzinger J; Cissé G
    Parasit Vectors; 2016 Oct; 9(1):554. PubMed ID: 27756339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.
    Phillips AE; Gazzinelli-Guimaraes PH; Aurelio HO; Ferro J; Nala R; Clements M; King CH; Fenwick A; Fleming FM; Dhanani N
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006061. PubMed ID: 29220347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of persistent hotspots of Schistosoma mansoni in western Côte d'Ivoire.
    Assaré RK; N'Tamon RN; Bellai LG; Koffi JA; Mathieu TI; Ouattara M; Hürlimann E; Coulibaly JT; Diabaté S; N'Goran EK; Utzinger J
    Parasit Vectors; 2020 Jul; 13(1):337. PubMed ID: 32616074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological and clinical aspects of urogenital schistosomiasis in women, in Burkina Faso, West Africa.
    Zida A; Briegel J; Kabré I; Sawadogo MP; Sangaré I; Bamba S; Yacouba A; Ouédraogo A; Yonli D; Drabo F; Traoré LK; Ouédraogo-Traoré R; Guiguemdé RT; Wacker J
    Infect Dis Poverty; 2016 Sep; 5(1):81. PubMed ID: 27581074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urogenital schistosomiasis in Cabo Delgado, northern Mozambique: baseline findings from the SCORE study.
    Phillips AE; Gazzinelli-Guimarães PH; Aurelio HO; Dhanani N; Ferro J; Nala R; Deol A; Fenwick A
    Parasit Vectors; 2018 Jan; 11(1):30. PubMed ID: 29316983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schistosomiasis - Assessing Progress toward the 2020 and 2025 Global Goals.
    Deol AK; Fleming FM; Calvo-Urbano B; Walker M; Bucumi V; Gnandou I; Tukahebwa EM; Jemu S; Mwingira UJ; Alkohlani A; Traoré M; Ruberanziza E; Touré S; Basáñez MG; French MD; Webster JP
    N Engl J Med; 2019 Dec; 381(26):2519-2528. PubMed ID: 31881138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combined school- and community-based campaign targeting all school-age children of Burkina Faso against schistosomiasis and soil-transmitted helminthiasis: performance, financial costs and implications for sustainability.
    Gabrielli AF; Touré S; Sellin B; Sellin E; Ky C; Ouedraogo H; Yaogho M; Wilson MD; Thompson H; Sanou S; Fenwick A
    Acta Trop; 2006 Oct; 99(2-3):234-42. PubMed ID: 16997268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human schistosomiasis in Benin: Countrywide evidence of Schistosoma haematobium predominance.
    Onzo-Aboki A; Ibikounlé M; Boko PM; Savassi BS; Doritchamou J; Siko EJ; Daré A; Batcho W; Massougbodji A; Tougoue JJ; Kaboré A
    Acta Trop; 2019 Mar; 191():185-197. PubMed ID: 30633895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Schistosomiasis endemic in Burkina Faso].
    Poda JN; Traoré A; Sondo BK
    Bull Soc Pathol Exot; 2004 Feb; 97(1):47-52. PubMed ID: 15104159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significantly reduced intensity of infection but persistent prevalence of schistosomiasis in a highly endemic region in Mali after repeated treatment.
    Landouré A; Dembélé R; Goita S; Kané M; Tuinsma M; Sacko M; Toubali E; French MD; Keita AD; Fenwick A; Traoré MS; Zhang Y
    PLoS Negl Trop Dis; 2012; 6(7):e1774. PubMed ID: 22860153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya.
    Gouvras AN; Kariuki C; Koukounari A; Norton AJ; Lange CN; Ireri E; Fenwick A; Mkoji GM; Webster JP
    Acta Trop; 2013 Nov; 128(2):309-17. PubMed ID: 23313322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.
    Kimani BW; Mbugua AK; Kihara JH; Ng'ang'a M; Njomo DW
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006852. PubMed ID: 30332403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Single Dose Praziquantel Treatment on Schistosoma haematobium Infection among School Children in an Endemic Nigerian Community.
    Adewale B; Mafe MA; Sulyman MA; Idowu ET; Ajayi MB; Akande DO; Mckerrow JH; Balogun EO
    Korean J Parasitol; 2018 Dec; 56(6):577-581. PubMed ID: 30630278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities.
    Ndeffo Mbah ML; Gilbert JA; Galvani AP
    Epidemics; 2014 Jun; 7():22-7. PubMed ID: 24928666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.